Erica L. Moran

610 total citations
17 papers, 435 citations indexed

About

Erica L. Moran is a scholar working on Molecular Biology, Rheumatology and Orthopedics and Sports Medicine. According to data from OpenAlex, Erica L. Moran has authored 17 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Rheumatology and 5 papers in Orthopedics and Sports Medicine. Recurrent topics in Erica L. Moran's work include Iron Metabolism and Disorders (4 papers), Bone health and treatments (3 papers) and Trace Elements in Health (3 papers). Erica L. Moran is often cited by papers focused on Iron Metabolism and Disorders (4 papers), Bone health and treatments (3 papers) and Trace Elements in Health (3 papers). Erica L. Moran collaborates with scholars based in Canada, Spain and United States. Erica L. Moran's co-authors include Earl R. Bogoch, Gerardo Jiménez, Victor Fornasier, James G. Wright, Mayka Sánchez, Curtis B. Caldwell, Amna Husain, Darin Jaturapatporn, Lourdes Ibáñez and Marta Díaz and has published in prestigious journals such as Molecular and Cellular Biology, Diabetes Care and Clinical Orthopaedics and Related Research.

In The Last Decade

Erica L. Moran

17 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erica L. Moran Canada 12 141 117 94 94 68 17 435
Pedro E. Huertas United States 9 325 2.3× 113 1.0× 105 1.1× 8 0.1× 34 0.5× 15 651
Meriem Koufany France 11 201 1.4× 88 0.8× 19 0.2× 21 0.2× 12 0.2× 16 348
Sang Yeob Lee South Korea 14 219 1.6× 154 1.3× 29 0.3× 22 0.2× 12 0.2× 35 527
Lorne E. Seargeant Canada 11 377 2.7× 200 1.7× 52 0.6× 12 0.1× 10 0.1× 14 679
Isabelle Redonnet‐Vernhet France 13 179 1.3× 86 0.7× 25 0.3× 18 0.2× 5 0.1× 26 398
Hidenori Nishida Japan 11 205 1.5× 32 0.3× 73 0.8× 29 0.3× 15 0.2× 14 410
Knut Uthne Sweden 13 256 1.8× 47 0.4× 57 0.6× 17 0.2× 18 0.3× 22 642
James M. Pash United States 15 401 2.8× 37 0.3× 27 0.3× 12 0.1× 20 0.3× 18 643
Alice Mazur United States 11 164 1.2× 66 0.6× 40 0.4× 7 0.1× 9 0.1× 13 570
RE Brenner Germany 6 254 1.8× 51 0.4× 52 0.6× 6 0.1× 28 0.4× 7 547

Countries citing papers authored by Erica L. Moran

Since Specialization
Citations

This map shows the geographic impact of Erica L. Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica L. Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica L. Moran more than expected).

Fields of papers citing papers by Erica L. Moran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica L. Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica L. Moran. The network helps show where Erica L. Moran may publish in the future.

Co-authorship network of co-authors of Erica L. Moran

This figure shows the co-authorship network connecting the top 25 collaborators of Erica L. Moran. A scholar is included among the top collaborators of Erica L. Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica L. Moran. Erica L. Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Joshi, Ricky S., Maya Shvartsman, Erica L. Moran, et al.. (2015). Functional consequences of transferrin receptor‐2 mutations causing hereditary hemochromatosis type 3. Molecular Genetics & Genomic Medicine. 3(3). 221–232. 16 indexed citations
2.
Falco, Luigia De, Laura Silvestri, Caroline Kannengiesser, et al.. (2014). Functional and Clinical Impact of NovelTmprss6Variants in Iron-Refractory Iron-Deficiency Anemia Patients and Genotype-Phenotype Studies. Human Mutation. 35(11). n/a–n/a. 39 indexed citations
3.
Luscieti, Sara, et al.. (2013). Novel mutations in the ferritin-L iron-responsive element that only mildly impair IRP binding cause hereditary hyperferritinaemia cataract syndrome. Orphanet Journal of Rare Diseases. 8(1). 30–30. 35 indexed citations
4.
Jaturapatporn, Darin, et al.. (2012). Patients' experiences of oxygen therapy and dyspnoea: a qualitative study in home palliative care. BMJ Supportive & Palliative Care. 2(Suppl 1). A47.1–A47. 3 indexed citations
5.
Joshi, Ricky S., Erica L. Moran, & Mayka Sánchez. (2012). Cellular Iron Metabolism – The IRP/IRE Regulatory Network. BiblioBoard Library Catalog (Open Research Library). 5 indexed citations
6.
Kannengiesser, Caroline, Mayka Sánchez, Marion Sweeney, et al.. (2011). Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia. Haematologica. 96(6). 808–813. 38 indexed citations
7.
Jaturapatporn, Darin, et al.. (2010). Patients’ experience of oxygen therapy and dyspnea: a qualitative study in home palliative care. Supportive Care in Cancer. 18(6). 765–770. 20 indexed citations
8.
López‐Bermejo, Abel, Marta Díaz, Erica L. Moran, Francis de Zegher, & Lourdes Ibáñez. (2010). A Single Nucleotide Polymorphism in STK11 Influences Insulin Sensitivity and Metformin Efficacy in Hyperinsulinemic Girls With Androgen Excess. Diabetes Care. 33(7). 1544–1548. 23 indexed citations
9.
Moran, Erica L. & Gerardo Jiménez. (2006). The Tailless Nuclear Receptor Acts as a Dedicated Repressor in the Early Drosophila Embryo. Molecular and Cellular Biology. 26(9). 3446–3454. 46 indexed citations
10.
Moran, Erica L., et al.. (2000). Carrageenan-Induced Arthritis in the Rat. Inflammation. 24(2). 141–155. 51 indexed citations
11.
Moran, Erica L., Victor Fornasier, & Earl R. Bogoch. (2000). Pamidronate prevents bone loss associated with carrageenan arthritis by reducing resorptive activity but not recruitment of osteoclasts. Journal of Orthopaedic Research®. 18(6). 873–881. 5 indexed citations
12.
Moran, Erica L., et al.. (2000). Changes in cross‐sectional geometry of the distal femoral metaphysis associated with inflammatory arthritis are reduced by a bisphosphonate (zoledronate). Journal of Orthopaedic Research®. 18(5). 734–738. 8 indexed citations
13.
Bogoch, Earl R. & Erica L. Moran. (1999). Bone Abnormalities in the Surgical Treatment of Patients With Rheumatoid Arthritis. Clinical Orthopaedics and Related Research. 366(366). 8–21. 45 indexed citations
14.
Caldwell, Curtis B., Erica L. Moran, & Earl R. Bogoch. (1998). Fractal Dimension as a Measure of Altered Trabecular Bone in Experimental Inflammatory Arthritis. Journal of Bone and Mineral Research. 13(6). 978–985. 29 indexed citations
15.
Moran, Erica L., et al.. (1997). Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis. Journal of Orthopaedic Research®. 15(6). 858–861. 22 indexed citations
16.
Bellingham, Catherine M., et al.. (1995). Bisphosphonate (pamidronate/APD) prevents arthritis‐induced loss of fracture toughness in the rabbit femoral diaphysis. Journal of Orthopaedic Research®. 13(6). 876–880. 9 indexed citations
17.
Wright, James G., Erica L. Moran, & Earl R. Bogoch. (1994). Reliability and validity of the grading of heterotopic ossification. The Journal of Arthroplasty. 9(5). 549–553. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pedro E. Huertas Breakdown of academic impact, for papers by Meriem Koufany Breakdown of academic impact, for papers by Sang Yeob Lee Breakdown of academic impact, for papers by Lorne E. Seargeant Breakdown of academic impact, for papers by Isabelle Redonnet‐Vernhet Breakdown of academic impact, for papers by Hidenori Nishida Breakdown of academic impact, for papers by Knut Uthne Breakdown of academic impact, for papers by James M. Pash Breakdown of academic impact, for papers by Alice Mazur Breakdown of academic impact, for papers by RE Brenner
Rankless by CCL
2026